US Patent Issued to Janssen Biotech on July 7 for "Materials and methods for modulating T cell mediated immunity" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,995, issued on July 7, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Materials and methods for modulating T cell mediated immunity" was invented by Rajkumar Ganesan (Blue Bell, Pa.), Iqbal S. Grewal (Newtown, Pa.) and Sanjaya Singh (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-TRGV9 antibodies or antigen binding fragments thereof are described. Also described are nucleic acids encoding the antibodies, compositions comprising the antibodies, methods of producing the antibodies, and methods of using the antibodies for treating or preventing diseases, such as cancer."

The patent was filed on April 25, 2023, under Applicati...